| Physical Therapy for Liver Cirrhosis (NCT04629456) | Cairo University | 2020-01-07 |
| Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I) (NCT04047160) | Kiminori Kimura, MD | 2019-08-29 |
| Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women (NCT03630718) | Assistance Publique - Hôpitaux de Paris | 2019-05-27 |
| Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (NCT03633227) | Intercept Pharmaceuticals | 2018-06-22 |
| Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis (NCT03476993) | Biocad | 2018-04-27 |
| BRIDGE Device for Post-operative Pain Control (NCT03265249) | Duke University | 2018-02-12 |
| Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia (NCT03468699) | Vinmec Research Institute of Stem Cell and Gene Technology | 2017-01-02 |
| Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome (NCT02936596) | Xiaoli Fan | 2016-12-01 |
| Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis (NCT02308111) | Intercept Pharmaceuticals | 2014-12-26 |
| Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC) (NCT00570765) | Intercept Pharmaceuticals | 2008-01-17 |
| Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC) (NCT00550862) | Intercept Pharmaceuticals | 2007-10-01 |
| Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis (NCT00406237) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-12-01 |
| SAMe to Treat Biliary Cirrhosis Symptoms (NCT00125281) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2005-07-25 |
| Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC) (NCT00145964) | University Health Network, Toronto | 2004-08-01 |
| Treatment of Cholestatic Pruritus With Sertraline (NCT00058903) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-04-01 |
| Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis (NCT00160940) | University Health Network, Toronto | 2002-02-01 |
| Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis (NCT00004842) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1997-05-01 |
| Ursodiol-Methotrexate for Primary Biliary Cirrhosis (NCT00006168) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1994-01-01 |
| Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis (NCT00004784) | National Center for Research Resources (NCRR) | 1994-01-01 |
| Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis (NCT00004748) | National Center for Research Resources (NCRR) | 1989-11-01 |